Home › Clinical Tools › TDM targets

🎯 Therapeutic Drug Monitoring (TDM) Targets

UseLook up the target range and when to sample (trough/peak/steady state). Interpret levels with clinical effica…

Loading calculator…

SourceTherapeutic drug monitoring guidance and product labelling

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Score + version; reference only — not a substitute for care · no HIS write

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

Units and assays vary between laboratories.

When to use

Look up the target range and when to sample (trough/peak/steady state). Interpret levels with clinical efficacy and toxicity.

How it works

Examples: digoxin 0.5–2.0 ng/mL (HF 0.5–0.9); phenytoin total 10–20 µg/mL; lithium 0.6–1.0 mmol/L; vancomycin AUC/MIC 400–600.

Key points

  • Units and assays vary between laboratories.
  • Wrong sampling timing (before steady state, not a true trough/peak) causes misinterpretation.
  • A subtherapeutic level with good clinical response need not be changed.
  • For vancomycin and aminoglycosides see the dedicated dosing tools.

References

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

DrugLithium

→Target rangeMaintenance 0.6–1.0, acute 0.8–1.2 mmol/L

  • Sampling:12 h after last dose (before the morning dose)
  • Toxicity:> 1.5 toxic; dehydration/NSAID/diuretic/ACEI raise it
DrugDigoxin

→Target range0.5–2.0 ng/mL (HF 0.5–0.9)

  • Sampling:≥ 6–8 h after last dose
  • Toxicity:> 2.0 toxic; hypokalaemia/hypomagnesaemia/renal impairment sensitise
Verification & sources · governance
FAQ

Frequently asked questions

What are the limits and cautions when using Therapeutic Drug Monitoring (TDM) Targets?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Therapeutic Drug Monitoring (TDM) Targets upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Therapeutic Drug Monitoring (TDM) Targets calculated in practice? Can you show a worked example?
Inputs: Drug Lithium → Result: Target range Maintenance 0.6–1.0, acute 0.8–1.2 mmol/L(Sampling: 12 h after last dose (before the morning dose), Toxicity: > 1.5 toxic; dehydration/NSAID/diuretic/ACEI raise it) Inputs: Drug Digoxin → Result: Target range 0.5–2.0 ng/mL (HF 0.5–0.9)(Sampling: ≥ 6–8 h after last dose, Toxicity: > 2.0 toxic; hypokalaemia/hypomagnesaemia/renal impairment sensitise)
Related tools